Todd A. Black, Ph.D. joined the TB Alliance in February 2021 as the Senior Director of Biology.
Prior to joining the TB Alliance, Todd was the Executive Director for Merck’s Infectious Diseases and Vaccines Basic Research group. He has worked the last 25 years on the discovery and development of novel therapies for infectious diseases at Novartis, Schering-Plough and Merck. Todd and his research teams have supported the discovery and development of a variety of therapies for prevention and treatment of infectious diseases, including new classes of antibiotics, antifungals for invasive infections, HIV and HCV antivirals, new classes of agents for treating and preventing recurrent C. difficile infections, in addition to vaccines to prevent prevalent respiratory and invasive infections. Todd’s passion has been on the prevention and treatment of emerging pathogens including multi-drug resistant bacteria and other emerging pathogens and is excited to be focusing on novel therapies for mycobacterial infections.
Todd earned his Ph. D. in Biochemistry at Michigan State University/DOE Plant Research Laboratory.